A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...
The Food and Drug Administration (FDA) has approved Iluvien® (fluocinolone acetonide intravitreal implant) for the treatment of chronic non-infectious ...
As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...
GlobalData on MSN5d
FDA approves early feasibility study of Valcare’s transcatheter deviceThe US Food and Drug Administration (FDA) has granted approval for Valcare Medical’s investigational device exemption ...
Clinical Trials Arena on MSN17h
Innovent & HUTCHMED seek approval of kidney cancer combo after Phase II/III trialInnovent and HUTCHMED received conditional approval for the combo in endometrial cancer from China’s NMPA last year.
Nikhil Lalwani, President and CEO of ANI stated, "ILUVIEN's expanded label and the strengthening of our partnership with long ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...
Michigan Gov. Gretchen Whitmer’s plan to tax e-cigarettes would also ban any vape products not approved by the FDA, treating ...
Despite concerns about the Trump government's shake-up of the agency, the US Food and Drug Administration remains the first ...
Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the U.S. Food and Drug ...
Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...
The acquired portfolio consists of 13 ANDAs already approved by the Food and Drug Administration and one pending approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback